In these normal-weight PCOS women, moreover, androgen receptor blockade by low-dose flutamide simultaneously decreases percent android fat and increases fasting glucose levels, supporting the role of androgen excess in the metabolic adaptation of PCOS through body fat distribution [16,79]. This evidence concerns the gene AR and polycystic ovary syndrome.